{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T18:24:17Z","timestamp":1770661457160,"version":"3.49.0"},"reference-count":171,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jconrel.2012.12.023","type":"journal-article","created":{"date-parts":[[2013,1,5]],"date-time":"2013-01-05T12:01:17Z","timestamp":1357387277000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Advancements in the field of intravaginal siRNA delivery"],"prefix":"10.1016","volume":"167","author":[{"given":"Sidi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roien","family":"Ahmadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel A.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2012.12.023_bb0005","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s11095-011-0604-5","article-title":"RNA interference and cancer therapy","volume":"28","author":"Wang","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4614-0332-6_3","article-title":"Plant RNA silencing in viral defence","volume":"722","author":"Pantaleo","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0020","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/45938","article-title":"RNA interference. Policing rogue genes","volume":"402","author":"Lin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0030","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.95.26.15502","article-title":"RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans","volume":"95","author":"Montgomery","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrg2364","article-title":"The art and design of genetic screens: RNA interference","volume":"9","author":"Boutros","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0060","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1126\/science.1102513","article-title":"Argonaute2 is the catalytic engine of mammalian RNAi","volume":"305","author":"Liu","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0065","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1126\/science.1088710","article-title":"R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway","volume":"301","author":"Liu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0092-8674(04)00258-2","article-title":"A Dicer-2-dependent 80S complex cleaves targeted mRNAs during RNAi in Drosophila","volume":"117","author":"Pham","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0075","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1261\/rna.101606","article-title":"Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes","volume":"12","author":"Liu","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/nar\/gkh208","article-title":"Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles","volume":"32","author":"Miller","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0085","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific silencing of dominant disease genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1474-9728.2003.00054.x","article-title":"Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis","volume":"2","author":"Ding","year":"2003","journal-title":"Aging Cell"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0095","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/sj.onc.1205653","article-title":"Killing of leukemic cells with a BCR\/ABL fusion gene by RNA interference","volume":"21","author":"Wilda","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymthe.2004.08.029","article-title":"Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo","volume":"11","author":"Pille","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0105","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1593\/neo.04313","article-title":"Silencing of the HER2\/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2\/neu-overexpressing breast cancer cells","volume":"6","author":"Faltus","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/hum.2006.17.1019","article-title":"Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer","volume":"17","author":"Pille","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0115","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.cdd.4401416","article-title":"Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L\/TRAIL-induced apoptosis","volume":"11","author":"Chawla-Sarkar","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1593\/tlo.11100","article-title":"STAT3 Knockdown in B16 melanoma by siRNA lipopolyplexes induces bystander immune response in vitro and in vivo","volume":"4","author":"Alshamsan","year":"2011","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdermsci.2005.12.016","article-title":"Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo","volume":"42","author":"Katagiri","year":"2006","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ijc.21350","article-title":"Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin","volume":"118","author":"Yonesaka","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0135","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1038\/sj.onc.1208459","article-title":"RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells","volume":"24","author":"Jiang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/cgt.2010.55","article-title":"Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism","volume":"18","author":"Wu","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0145","first-page":"1291","article-title":"Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells","volume":"9","author":"Verma","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0150","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1074\/jbc.M510023200","article-title":"Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer","volume":"281","author":"Wilson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0155","first-page":"842","article-title":"Inhibition of HBV replication by siRNA in a stable HBV-producing cell line","volume":"38","author":"Konishi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-5793(03)00400-9","article-title":"Short interfering RNA-directed inhibition of hepatitis B virus replication","volume":"543","author":"Hamasaki","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0165","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbrc.2005.07.170","article-title":"Stable inhibition of hepatitis B virus expression and replication by expressed siRNA","volume":"335","author":"Ren","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0170","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3748\/wjg.v10.i13.1898","article-title":"Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells","volume":"10","author":"Liu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0175","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1525-0016(03)00244-2","article-title":"Small interfering RNA inhibits hepatitis B virus replication in mice","volume":"8","author":"Giladi","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0180","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0185","first-page":"56","article-title":"Inhibition of herpes simplex virus type 1 by small interfering RNA","volume":"33","author":"Zhang","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0190","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00705-008-0110-1","article-title":"Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA","volume":"153","author":"Zhe","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature04263","article-title":"An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection","volume":"439","author":"Palliser","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0200","first-page":"F55","article-title":"Papillomavirus infections \u2014 A major cause of human cancers","volume":"1288","author":"zurHausen","year":"1996","journal-title":"Bba-Rev. Cancer"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0205","first-page":"541","article-title":"Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer","volume":"29","author":"Fujii","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719106298189","article-title":"Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells","volume":"14","author":"Lea","year":"2007","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0215","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1038\/sj.onc.1205878","article-title":"Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference","volume":"21","author":"Jiang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0220","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/ijgc-00009577-200603000-00044","article-title":"Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo","volume":"16","author":"Niu","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1525-0016(03)00140-0","article-title":"Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34(+) progenitor cell-derived macrophages","volume":"8","author":"Banerjea","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nbt0502-500","article-title":"Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells","volume":"20","author":"Lee","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0235","doi-asserted-by":"crossref","first-page":"9225","DOI":"10.1128\/JVI.76.18.9225-9231.2002","article-title":"Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference","volume":"76","author":"Coburn","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0240","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1093\/nar\/gkf627","article-title":"Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference","volume":"30","author":"Park","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0245","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature00896","article-title":"Modulation of HIV-1 replication by RNA interference","volume":"418","author":"Jacque","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0250","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm725","article-title":"siRNA-directed inhibition of HIV-1 infection","volume":"8","author":"Novina","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0255","doi-asserted-by":"crossref","first-page":"12963","DOI":"10.1128\/JVI.76.24.12963-12973.2002","article-title":"RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication","volume":"76","author":"Surabhi","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0260","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/00002030-200212060-00002","article-title":"Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication","volume":"16","author":"Martinez","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0265","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/biot.201100054","article-title":"Current progress of siRNA\/shRNA therapeutics in clinical trials","volume":"6","author":"Burnett","year":"2011","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0270","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.05662-11","article-title":"Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring","volume":"56","author":"Moss","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0684.1997.tb00316.x","article-title":"Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees","volume":"26","author":"Bagarazzi","year":"1997","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0169-409X(92)90008-E","article-title":"(D) Routes of delivery: case studies: (8) the vaginal route of peptide and protein drug delivery","volume":"8","author":"Richardson","year":"1992","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0285","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18433\/J3HP41","article-title":"Strategies to prolong the intravaginal residence time of drug delivery systems","volume":"12","author":"Baloglu","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0290","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0295","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/03639045.2011.623355","article-title":"Vaginal mucoadhesive drug delivery systems","volume":"38","author":"Pereira","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0300","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bpobgyn.2012.01.010","article-title":"Overview of microbicides for the prevention of human immunodeficiency virus","volume":"26","author":"Karim","year":"2012","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0305","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1128\/JVI.77.10.6066-6069.2003","article-title":"RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells","volume":"77","author":"Hall","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0310","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chom.2008.12.003","article-title":"Durable protection from herpes simplex virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene","volume":"5","author":"Wu","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0315","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2008.06.034","article-title":"T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice","volume":"134","author":"Kumar","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0320","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2008.06.011","article-title":"State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers","volume":"364","author":"Fattal","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0325","first-page":"301","article-title":"RNA-based gene therapy for the treatment and prevention of HIV: from bench to bedside","volume":"84","author":"Zeller","year":"2011","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1359-6446(05)03668-8","article-title":"Harnessing in vivo siRNA delivery for drug discovery and therapeutic development","volume":"11","author":"Xie","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0340","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.20194","article-title":"Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis","volume":"93","author":"Kieweg","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0345","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1115\/1.2206198","article-title":"Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery","volume":"128","author":"Kieweg","year":"2006","journal-title":"J. Biomech. Eng."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0350","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/wnan.144","article-title":"Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?","volume":"3","author":"das Neves","year":"2011","journal-title":"Wires Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/bj2170093","article-title":"Hydrodynamic properties of human cervical-mucus glycoproteins in 6M-guanidinium chloride","volume":"217","author":"Sheehan","year":"1984","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0360","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0003-2697(89)90735-5","article-title":"Quantitation of mucus glycoproteins blotted onto nitrocellulose membranes","volume":"182","author":"Thornton","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0365","first-page":"G613","article-title":"Mucin gene structure and expression: protection vs. adhesion","volume":"269","author":"Van Klinken","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0370","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0375","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.addr.2004.03.001","article-title":"Nanoscale technology of mucoadhesive interactions","volume":"56","author":"Peppas","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0380","first-page":"479","article-title":"Ultrastructure of the human periovulatory cervical mucus","volume":"54","author":"Ceric","year":"2005","journal-title":"J. Electron Microsc."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0385","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0390","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0395","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejpb.2008.09.022","article-title":"Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents","volume":"71","author":"Serra","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0400","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2164\/jandrol.04104","article-title":"A review of the physical and chemical properties of human semen and the formulation of a semen simulant","volume":"26","author":"Owen","year":"2005","journal-title":"J. Androl."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0405","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/cdli.4.3.367-374.1997","article-title":"In vivo semen-associated pH neutralization of cervicovaginal secretions","volume":"4","author":"Tevi-Benissan","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0410","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2011.02.002","article-title":"Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system","volume":"155","author":"Wu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0415","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2011.06.007","article-title":"pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0420","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199834030-00003","article-title":"Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs","volume":"34","author":"Kashuba","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0425","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/sj.onc.1206733","article-title":"Use of adeno-associated viral vector for delivery of small interfering RNA","volume":"22","author":"Tomar","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0430","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1073\/pnas.232688199","article-title":"Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5","volume":"100","author":"Qin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0435","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1158\/0008-5472.CAN-04-0953","article-title":"Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA","volume":"64","author":"Li","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0440","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.242594499","article-title":"Retroviral delivery of small interfering RNA into primary cells","volume":"99","author":"Barton","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0445","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1535-6108(02)00122-8","article-title":"Stable suppression of tumorigenicity by virus-mediated RNA interference","volume":"2","author":"Brummelkamp","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0450","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/hum.2004.15.1157","article-title":"The innate immune response to adenovirus vectors","volume":"15","author":"Muruve","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0455","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.gt.3302039","article-title":"Immune responses to adeno-associated virus and its recombinant vectors","volume":"10","author":"Sun","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0460","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nmat2444","article-title":"Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA","volume":"8","author":"Woodrow","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0465","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s13346-011-0048-9","article-title":"Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid)","volume":"2","author":"Yu","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0470","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jps.23351","article-title":"Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model","volume":"102","author":"Ho","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0475","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.biophys.29.1.27","article-title":"Structure and function of lipid-DNA complexes for gene delivery","volume":"29","author":"Chesnoy","year":"2000","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0480","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/02652040500273753","article-title":"Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol","volume":"22","author":"Budhian","year":"2005","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0485","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.11.028","article-title":"Encapsulation of dexamethasone into biodegradable polymeric nanoparticles","volume":"331","author":"Gomez-Graete","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0490","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1166\/jbn.2008.328","article-title":"Polymeric nanocarriers for siRNA delivery: challenges and future prospects","volume":"4","author":"Cun","year":"2008","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0495","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2010.11.008","article-title":"High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization","volume":"77","author":"Cun","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0500","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2009.10.023","article-title":"Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery","volume":"390","author":"Cun","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0505","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2012.06.008","article-title":"Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection","volume":"162","author":"Steinbach","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0510","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmat2456","article-title":"Drug delivery: old polymer learns new tracts","volume":"8","author":"Campolongo","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0515","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2010.06.029","article-title":"Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: a mini-review","volume":"148","author":"Peer","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0520","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0525","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0530","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-3659(01)00259-0","article-title":"Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications","volume":"72","author":"Bures","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0535","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-3659(99)00233-3","article-title":"Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces","volume":"65","author":"Huang","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0540","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus","volume":"6","author":"Cu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0545","doi-asserted-by":"crossref","first-page":"50393","DOI":"10.1074\/jbc.M309026200","article-title":"Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport","volume":"278","author":"Dawson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0550","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/(SICI)1097-4628(19970314)63:11<1481::AID-APP10>3.0.CO;2-5","article-title":"Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin","volume":"63","author":"Norris","year":"1997","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0555","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(98)00346-9","article-title":"Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract","volume":"177","author":"Sakuma","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0560","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-3659(02)00072-X","article-title":"Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine","volume":"81","author":"Sakuma","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0565","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0570","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijpharm.2006.11.018","article-title":"Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes","volume":"331","author":"Romberg","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0575","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo \u2014 polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0580","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.gt.3302425","article-title":"RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo","volume":"12","author":"Urban-Klein","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0585","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jgm.277","article-title":"Intracellular processing and stability of DNA complexed with histidylated polylysine conjugates","volume":"4","author":"Goncalves","year":"2002","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0590","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jgm.577","article-title":"Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer","volume":"6","author":"Huth","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0595","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpharm.2008.09.039","article-title":"Polymeric nanoparticles for siRNA delivery and gene silencing","volume":"367","author":"Patil","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0600","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5012\/bkcs.2007.28.1.095","article-title":"Apoptosis induced by polyethylenimine\/DNA complex in polymer mediated gene delivery","volume":"28","author":"Lee","year":"2007","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0605","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.biomaterials.2006.09.026","article-title":"Cytotoxicity of polyethyleneimine (PEI), precursor base layer of polyelectrolyte multilayer films","volume":"28","author":"Brunot","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0610","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1208\/ps040312","article-title":"Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures","volume":"4","author":"Florea","year":"2002","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0615","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/bc800065f","article-title":"Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity","volume":"19","author":"Zintchenko","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0620","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jgm.1490","article-title":"The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery","volume":"12","author":"Oskuee","year":"2010","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0625","first-page":"46","article-title":"Effect of poly(ethylene glycol) grafting on polyethylenimine as a gene transfer vector in vitro","volume":"22","author":"Choi","year":"2001","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0630","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2005.09.020","article-title":"Replication-defective viruses as vaccines and vaccine vectors","volume":"344","author":"Dudek","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0635","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.326_652","article-title":"Beyond Thailand: making sense of a qualified AIDS vaccine \"success\"","volume":"326","author":"Cohen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0640","first-page":"126","article-title":"The development and future of oligonucleotide-based therapies for cervical cancer","volume":"9","author":"Gu","year":"2007","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0645","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1517\/14712590802653619","article-title":"Towards a durable RNAi gene therapy for HIV-AIDS","volume":"9","author":"Berkhout","year":"2009","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0650","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/hum.2008.928","article-title":"Delivery vehicles for small interfering RNA in vivo","volume":"19","author":"De Fougerolles","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0655","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2747","article-title":"The structural biology of HIV-1: mechanistic and therapeutic insights","volume":"10","author":"Engelman","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0660","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1073\/pnas.0705474104","article-title":"Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates","volume":"104","author":"An","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0665","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/mt.2009.271","article-title":"RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice","volume":"18","author":"Kim","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0670","first-page":"152","article-title":"Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization","volume":"52","author":"Anderson","year":"2009","journal-title":"Jaids-J. Acq. Imm. Def."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0675","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/gt.2008.124","article-title":"Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-\/-)gamma(-\/-)(c)) mouse model","volume":"16","author":"ter Brake","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0680","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-4690-4-80","article-title":"Optimal design and validation of antiviral siRNA for targeting HIV-1","volume":"4","author":"Naito","year":"2007","journal-title":"Retrovirology"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0685","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1128\/JVI.77.13.7174-7181.2003","article-title":"Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages","volume":"77","author":"Song","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0690","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/338231","article-title":"Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis","volume":"185","author":"Wald","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0695","first-page":"435","article-title":"The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics","volume":"35","author":"Corey","year":"2004","journal-title":"Jaids-J. Acq. Imm. Def."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0700","first-page":"447","article-title":"Genital herpes and human immunodeficiency virus: double trouble","volume":"82","author":"Celum","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0705","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","article-title":"Estimates of the world-wide prevalence of cancer for 25 sites in the adult population","volume":"97","author":"Pisani","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0710","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/jvi.61.4.1061-1066.1987","article-title":"Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA","volume":"61","author":"Pirisi","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0715","first-page":"251","article-title":"Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type-16 DNA","volume":"1","author":"Durst","year":"1987","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0720","first-page":"337","article-title":"Cellular and molecular alterations in human epithelial-cells transformed by recombinant human papillomavirus DNA","volume":"4","author":"Dipaolo","year":"1993","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0725","first-page":"7075","article-title":"The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability","volume":"62","author":"Duensing","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0730","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/jvi.63.3.1441-1447.1989","article-title":"Oncogenic and nononcogenic human genital papillomaviruses generate the E7 messenger-Rna by different mechanisms","volume":"63","author":"Smotkin","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0735","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/j.1460-2075.1986.tb04496.x","article-title":"Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes","volume":"5","author":"Schneider-Gadicke","year":"1986","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0740","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1073\/pnas.110538897","article-title":"Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein","volume":"97","author":"Butz","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0745","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1038\/sj.onc.1206894","article-title":"siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells","volume":"22","author":"Butz","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0750","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ymthe.2003.08.004","article-title":"In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA","volume":"8","author":"Yoshinouchi","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0755","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2008.04.038","article-title":"Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine","volume":"360","author":"Kanazawa","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0760","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1211\/jpp.61.11.0004","article-title":"Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses","volume":"61","author":"Kanazawa","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0765","doi-asserted-by":"crossref","first-page":"42625","DOI":"10.1074\/jbc.M301431200","article-title":"Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways","volume":"278","author":"Ignatovich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0770","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/sj.gt.3302128","article-title":"Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation","volume":"11","author":"Khalil","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0775","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2004.09.018","article-title":"Influence of TAT-peptide polymerization on properties and transfection activity of TAT\/DNA polyplexes","volume":"102","author":"Soundara Manickam","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0780","first-page":"232","article-title":"Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer","volume":"1816","author":"Bolhassani","year":"2011","journal-title":"Bba-Rev. Cancer"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0785","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-61779-188-8_5","article-title":"Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides","volume":"764","author":"El Andaloussi","year":"2011","journal-title":"Meth. Mol. Biol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0790","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbrc.2012.01.041","article-title":"Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation","volume":"418","author":"Amand","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0795","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.biomaterials.2011.04.053","article-title":"Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides","volume":"32","author":"Chene","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0800","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/bc200324q","article-title":"Cell-penetrating conjugates of coproporphyrins with oligoarginine peptides: rational design and application for sensing intracellular O2","volume":"22","author":"Dmitriev","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0805","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2174\/138920111796117391","article-title":"Cell penetrating peptides for tumor targeting","volume":"12","author":"Choi","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0810","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11095-007-9303-7","article-title":"Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives","volume":"24","author":"Patel","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0815","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2012.02.002","article-title":"Peptides for cell-selective drug delivery","volume":"33","author":"Svensen","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0820","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10717544.2011.567310","article-title":"Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements","volume":"18","author":"Koren","year":"2011","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0825","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/ph3123594","article-title":"Cell-Penetrating Penta-Peptides (CPP5s): measurement of cell entry and protein-transduction activity","volume":"3","author":"Gomez","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0830","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/bip.21641","article-title":"Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides","volume":"95","author":"Rullo","year":"2011","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2012.12.023_bb0835","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1172\/JCI45876","article-title":"Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras","volume":"121","author":"Wheeler","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0840","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","article-title":"Inhibition of respiratory viruses by nasally administered siRNA","volume":"11","author":"Bitko","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0845","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymthe.2006.04.001","article-title":"Engineering mucosal RNA interference in vivo","volume":"14","author":"Zhang","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0850","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.02.049","article-title":"Chemical modification of siRNAs to improve serum stability without loss of efficacy","volume":"342","author":"Choung","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2012.12.023_bb0855","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/78119","article-title":"Mutations of PVRL1, encoding a cell\u2013cell adhesion molecule\/herpesvirus receptor, in cleft lip\/palate-ectodermal dysplasia","volume":"25","author":"Suzuki","year":"2000","journal-title":"Nat. Genet."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912008656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912008656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:27:11Z","timestamp":1759159631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365912008656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0168365912008656"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.12.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in the field of intravaginal siRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}